Human Respiratory Infections in Nigeria: Influenza and the Emergence of SARS-CoV-2 Pandemic

Vaccines (Basel). 2022 Sep 17;10(9):1551. doi: 10.3390/vaccines10091551.

Abstract

The increasing outbreak of zoonotic diseases presents challenging times for nations and calls for a renewed effort to disrupt the chain of events that precede it. Nigeria's response to the 2006 bird flu provided a platform for outbreak response, yet it was not its first experience with Influenza. This study describes the impact of SARS-CoV-2 on Influenza surveillance and, conversely, while the 1918 Influenza pandemic remains the most devastating (500,000 deaths in 18 million population) in Nigeria, the emergence of SARS CoV-2 presented renewed opportunities for the development of vaccines with novel technology, co-infection studies outcome, and challenges globally. Although the public health Intervention and strategies left some positive outcomes for other viruses, Nigeria and Africa's preparation against the next pandemic may involve prioritizing a combination of technology, socioeconomic growth, and active surveillance in the spirit of One Health.

Keywords: Nigeria; SARS-CoV-2; influenza; pandemic.

Publication types

  • Review

Grants and funding

This research received no external funding.